Navigation Links
Acrylamide Raises Kidney Cancer Risk
Date:5/9/2008

snack, Dutch spiced cake, was the main source of the chemical for those consuming the most. The relationship was found to be stronger for smokers.

For each additional 10 micrograms ingested of the chemical, kidney cancer risk increased by 10 percent, the researchers found.

In another study published in the same issue of the journal, researchers found no association between dietary fat intake and prostate cancer risk.

One expert praised the acrylamide study but added that more research is needed. It is also difficult to know how much impact smoking has on the cancer risk, said Marji McCullough, a nutritional epidemiologist for the American Cancer Society.

"Smoking is a [known] risk factor for this [kidney] cancer," she said.

Exactly how the acrylamide boosts cancer risk isn't known, she added, "but the hypothesis is that metabolites [breakdown products] of the acrylamide cause DNA damage."

Limiting the consumption of foods containing the chemical is wise, Hogervorst said. "Also, in preparing food at home, fry potatoes at temperatures below 175 degrees Celsius and fry them to gold-yellow, not dark brown [the more brown, the more acrylamide]. The same goes for making toast and cookies."

McCullough added: "It's best not to smoke and to maintain an ideal body weight. One way to maintain a healthy body weight is a healthy diet."

And that, of course, means limiting the French fries and other snacks.

More information

To learn more about kidney cancer, visit the American Cancer Society.



SOURCES: Marji McCullough, Sc.D., R.D., nutritional epidemiologist, American Cancer Society, Atlanta; Janneke Hogervorst, M.Sc., Maastricht University, Maastricht, the Netherlands; May 2008, American Journal of Clinical N
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Acrylamide Wont Raise Breast Cancer Risk
2. Reese Witherspoon Helps Celebrate Avon Walk for Breast Cancer Washington, D.C. - Weekend-Long Event Raises $8.1 Million
3. Astute Medical Raises $6.2 Million in Series A Financing Round Led by De Novo Ventures
4. Study raises questions about prostate cancer therapies targeting IGF-1
5. Report raises C. diff concerns; yeast-based probiotic shown to help significantly reduce recurrence
6. USCCB Official Praises Senate Passage of Genetic Information Nondiscrimination Act
7. The Womens Health II Medical Education Network Raises Awareness About the Diagnosis and Management of Womens Health Issues
8. VisEn Medical Raises $5.0 Million in Expanded Series B Financing
9. Consumer Watchdog Praises CA HMO Regulators Promise to Reinstate Health Coverage for Wrongfully Cancelled Patients; Cautions That All Health Costs During Gap Must be Covered
10. FRC Action Praises John McCains Pro-Life Comments
11. Standard & Poors Raises Gerresheimer Rating to BB+
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Acrylamide Raises Kidney Cancer Risk
Acrylamide Raises Kidney Cancer Risk
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...ong Kong experts concluded that there is a genetic...at SARS is transmitted to human beings through// c...e Information Times newspaper on Thursday. The r...et cats, by the Center for Disease Control and Pro...
... adolescents are enjoying the health and social be...ny observers have noted problems related to// over...le sport medicine physicians have seen alarming in...es. The November/December issue of the Clinical Jo...
...n funds to the tune of SFr25 million ($20 million)... Technology in Lausanne to invest in the creation ... the brain. The joint venture, envisaged for five...er in children. Also research to lessen the impact...
...cials have banned the sale of turbot after they de...//at several of Beijing’s fish markets, reports th... Cao Jilin from Europe in 1992. Due to low resist...medicinal supplements, which sometime leave harmfu...
Other Medicine News:Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 2Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 3
(Date:10/10/2008)...tment with Kogenate FS Reduces the,Risk of Joint D...Existing,Joint Damage, BERKELEY, Calif., Oct. 10 ...ay that the U.S. Food and Drug Administration (FDA...) FS Antihemophilic Factor,(Recombinant) to reduce...f,joint damage in patients aged 0-16 years with se...
(Date:10/9/2008)...e need to protect the eyesight of,older people, N...people worldwide who,are blind, 80 percent are ove...oided their blindness if they had been properly di...Release, go to:, http://www.prnewswire.com/mnr/orb... products and equipment, is,partnering with nonpro...
(Date:10/8/2008)...e-USNewswire/ -- The facts are,overwhelming. Every...-Saharan Africa. More than 35,000,000 women, child...ed of AIDS. The Foundation for Hospices,in Sub-Sah...ir families,find compassion and relief from suffer...ing initiative links African hospices and palliati...
(Date:10/8/2008)...ts Expand Testing Using Cellular ... Oct. 8 /- Wild Blueberry antioxidant...ts from a new study,showing Wild Blueberries outpe...e apples, bananas, red grapes and strawberries in ...tivity (CAA) assay. New research,published in the ...
Breaking Medicine Technology:FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 1909 1ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 1909 2ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 1909 3Exelixis Announces May 6 Webcast of Its First Quarter 2008 Financial Results and Business Update Conference Call 4896 1Story of Womans Courage and Medical Innovation Top Choice for Readers 17825 1Story of Womans Courage and Medical Innovation Top Choice for Readers 17825 2Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 4894 1Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 4894 2Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 4894 3Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 4894 4
...un 7, 2007 - Clinical results from a,Phase II stud...dache Society (AHS) annual meeting showed that MK-...ted peptide (CGRP),receptor antagonist, significan...dosing compared to placebo, and the relief was,sus...l tolerated in,the study. Responses specific to ot...
...ndpoints for Both Efficacy and Safety, LEXINGTON, ...evus Pharmaceuticals, Inc. today announced final r...r NEBIDO (testosterone,undecanoate), a long- actin...t for the treatment of male hypogonadism which the...ermany. The data,from the recently completed 48-we...
Other Medicine Technology:Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5Indevus Reports Positive Data From Phase III NEBIDO Trial 2Indevus Reports Positive Data From Phase III NEBIDO Trial 3Indevus Reports Positive Data From Phase III NEBIDO Trial 4Indevus Reports Positive Data From Phase III NEBIDO Trial 5Indevus Reports Positive Data From Phase III NEBIDO Trial 6
...ed on the competition principle and the microplate...n the sample and a fixed amount of DHEA-S conjugat...nding sites of a polyclonal DHEA-S antiserum coate...crotiterplate is washed to stop the competition re...
EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM.
Latex agglutination test for the qualitative and semiquantitative determination of rheumatoid factor in serum.
Equipped with the SYNCHRON CX4 PRO, which includes many of today's most advanced and automated technologies, your laboratory can improve its specialty testing process dramatically. The SYNCHRON CX4 P
Medicine Products: